Baxter's Intravenous Fluids North Cove Plant was impacted in September by Hurricane Helene. Although Baxter implemented a hurricane preparedness plan, a levy breach and bridge collapse forced a complete shutdown. Intravenous fluids are now on allocation as the plant remains shuttered. Multiple actions by the FDA and Baxter are in effect to improve supply for these fluids. Vizient colleagues Katie Korte, VP Assurance and Continuity Team and Kyle Hoelting, Senior Clinical Manager of Drug Information and Shortages join Stacy Lauderdale, Associate Vice president of Evidence-based Medicine today to discuss lessons learned from this and past supply disruptions, ongoing efforts by the FDA to improve supplies and the supply outlook for the next four to eight weeks

Guest speakers:

Katie Korte, PharmD, MHA

VP Assurance and Continuity Team

Vizient

Kyle Holting, PharmD, BCPS

Senior Clinical Manager of Drug Information and Shortages

Vizient Center for Pharmacy Practice Excellence

Host:

Stacy Lauderdale, PharmD, BCPS

Associate Vice president of Evidence-based Medicine

Vizient Center for Pharmacy Practice Excellence 

Show Notes:

[00:57-01:27] Guest’s background information

[01:28-04:33] Recent supply disruptions

[04:34-05:54] What Vizient has learned from past disruptions

[05:55-09:30] What providers have learned from these shortages

[09:31-13:42] What the FDA is doing to assist with this shortage

[13:43-18:23] What the trajectory of this shortage looks like over the next four to eight weeks

[18:24-19:45] Most important thing to emphasize to our listeners as they continue to handle this fluid shortage

Links | Resources:

Vizient’s IV push list: Click here

Vizient’s IV fluid conservation strategies: Click here

Baxter’s North Cove facility website: Click here

FDA’s Baxter North Cove facility website: Click here

Subscribe Today!

Apple Podcasts

Amazon Podcasts

Spotify

Android

RSS Feed

The Pharmacy Vision Awards at Vizient celebrate values and achievements of our program participants. Elham Amiri, pharmacy informatics project manager at UCSF Health, is a recipient of the professional excellence award, given to an individual who demonstrates leadership, strategic contribution and commitment to ongoing learning and development. Elham and Dr. Noelle Chapman, vice president, chief pharmacy officer and COO at UCSF Health, join us today to discuss their award-winning program.

Guest speakers: Elham Amiri, CPhT, CSPT, BS Pharmacy Informatics Project Manager UCSF Health

Noelle Chapman, PharmD, MBA Vice president, Chief Pharmacy Officer and COO UCSF Health

Host: Carolyn Liptak, BS Pharmacy, MBA  Pharmacy Executive Director  Vizient Center for Pharmacy Practice Excellence 

Show Notes:

[00:52-02:07] Guest’s background information

[02:08-03:32] Their great work at UCSF Health

[03:33-05:49] How their work contributed to the Pharmacy Value Improvement Program

[05:50-07:27] Taking a roll and running with it

[07:28-09:25] How UCSF supports professional development

[09:25-10:24] How patients benefit from this model

[10:25-13:45] What does the future hold

Subscribe Today!

Apple Podcasts

Amazon Podcasts

Spotify

Android

RSS Feed

We emerged from the COVID -19 pandemic in 2022 to headlines about unseasonably early spikes in respiratory syncytial virus and concerns and threats of a triple pandemic of CV19, influenza, and RSV. Fortunately, there’s been no triple pandemic, but what has emerged is multiple first-time vaccine approvals for RSV. Dr. John Schoen, Senior Manager of Drug Information at The Vizient Center for Phamacy Practice Excellence joins his colleague and Program Host Stacy Lauderdale, Associate Vice President of Evidence-Based Medicine to discuss the use of the RSV vaccines.

Guest speakers: John Schoen, PharmD, BCPS Senior Manager of Drug Information Vizient Center for Pharmacy Practice Excellence

Host: Stacy Lauderdale, PharmD, BCPS Associate Vice President of Evidence-Based Medicine Vizient Center for Pharmacy Practice Excellence VerifiedRx Host

Show Notes:

[00:55-01:46] John’s background

[01:47 -03:15] The RSV disease burden in older adults, and risk factors

[03:16-04:42] The relative disease severity of RSV versus influenza

[04:43-07:04] Vaccine uptake during the last RSV season

[07:05-8:35] Efficacy of the RSV vaccines in observational data compared to the clinical trials

[8:36-11:22] Changes in ACIP recommendations

[11:23-13:14] Potential benefits of RSV vaccination for ages older than 75

[13:15-15:32] Potential adverse reactions of RSV vaccines

[15:33-18:31] Comparisons of the RSV vaccines

[18:32-20:46] Are patients going to need more than one RSV vaccine?

Subscribe Today!

Apple Podcasts

Amazon Podcasts

Spotify

Android

RSS Feed